548 related articles for article (PubMed ID: 31485599)
21. Long non-coding RNA nuclear enriched abundant transcript 1 (NEAT1) modulates inhibitor of DNA binding 1 (ID1) to facilitate papillary thyroid carcinoma development by sponging microRNA-524-5p.
Liao G; Huang Z; Gan T; Wu C; Wang X; Li D
Bioengineered; 2022 May; 13(5):13201-13212. PubMed ID: 35635748
[TBL] [Abstract][Full Text] [Related]
22. Knockdown of the oncogene lncRNA NEAT1 restores the availability of
Hu Y; Yang Q; Wang L; Wang S; Sun F; Xu D; Jiang J
Biosci Rep; 2018 Jun; 38(3):. PubMed ID: 29654165
[TBL] [Abstract][Full Text] [Related]
23. Long noncoding RNA NEAT1 promotes the growth of gastric cancer cells by regulating miR-497-5p/PIK3R1 axis.
Xia TF; Chen J; Wu K; Zhang J; Yan Q
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6914-6926. PubMed ID: 31486491
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA‑9‑5p downregulates Klf4 and influences the progression of hepatocellular carcinoma via the AKT signaling pathway.
Dong X; Wang F; Xue Y; Lin Z; Song W; Yang N; Li Q
Int J Mol Med; 2019 Mar; 43(3):1417-1429. PubMed ID: 30664155
[TBL] [Abstract][Full Text] [Related]
25. LncRNA NEAT1 promotes the tumorigenesis of colorectal cancer by sponging miR-193a-3p.
Yu HM; Wang C; Yuan Z; Chen GL; Ye T; Yang BW
Cell Prolif; 2019 Jan; 52(1):e12526. PubMed ID: 30407674
[TBL] [Abstract][Full Text] [Related]
26. Long non-coding RNA LINC00337 induces autophagy and chemoresistance to cisplatin in esophageal squamous cell carcinoma cells via upregulation of TPX2 by recruiting E2F4.
Yang C; Shen S; Zheng X; Ye K; Ge H; Sun Y; Lu Y
FASEB J; 2020 May; 34(5):6055-6069. PubMed ID: 32239565
[TBL] [Abstract][Full Text] [Related]
27. Transcript-level regulation of MALAT1-mediated cell cycle and apoptosis genes using dual MEK/Aurora kinase inhibitor "BI-847325" on anaplastic thyroid carcinoma.
Samimi H; Haghpanah V; Irani S; Arefian E; Sohi AN; Fallah P; Soleimani M
Daru; 2019 Jun; 27(1):1-7. PubMed ID: 31077090
[TBL] [Abstract][Full Text] [Related]
28. CRSP8 promotes thyroid cancer progression by antagonizing IKKα-induced cell differentiation.
Liao Y; Hua Y; Li Y; Zhang C; Yu W; Guo P; Zou K; Li W; Sun Y; Wang R; Zuo Y; Sui S; Tian C; Hao J; Chen M; Hu S; Chen M; Long Q; Wang X; Zou L; Xie F; Guo W; Deng W
Cell Death Differ; 2021 Apr; 28(4):1347-1363. PubMed ID: 33162555
[TBL] [Abstract][Full Text] [Related]
29. Roles of the SNHG7/microRNA‑9‑5p/DPP4 ceRNA network in the growth and
Chen W; Yu J; Xie R; Zhou T; Xiong C; Zhang S; Zhong M
Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33649840
[TBL] [Abstract][Full Text] [Related]
30. Downregulation of CSN6 attenuates papillary thyroid carcinoma progression by reducing Wnt/β-catenin signaling and sensitizes cancer cells to FH535 therapy.
Wen D; Liao T; Ma B; Qu N; Shi RL; Lu ZW; Wang YL; Wei WJ; Ji QH
Cancer Med; 2018 Feb; 7(2):285-296. PubMed ID: 29341469
[TBL] [Abstract][Full Text] [Related]
31. Upregulation of nuclear-enriched abundant transcript 1 confers oxaliplatin resistance to gastric cancer.
Li Y; Peng C; Fang C; Huang K
Cell Biol Int; 2020 Feb; 44(2):446-455. PubMed ID: 31617275
[TBL] [Abstract][Full Text] [Related]
32. Inhibitor of apoptosis protein Livin promotes tumor progression and chemoradioresistance in human anaplastic thyroid cancer.
Kim HK; Kim SA; Jung EK; Lee KH; Lee JK; Kang HC; Joo YE; Lim SC; Yoon TM
Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33649820
[TBL] [Abstract][Full Text] [Related]
33. Effects of miR-144 on the sensitivity of human anaplastic thyroid carcinoma cells to cisplatin by autophagy regulation.
Liu J; Feng L; Zhang H; Zhang J; Zhang Y; Li S; Qin L; Yang Z; Xiong J
Cancer Biol Ther; 2018 Jun; 19(6):484-496. PubMed ID: 29504819
[TBL] [Abstract][Full Text] [Related]
34. Overexpression of RYBP inhibits proliferation, invasion, and chemoresistance to cisplatin in anaplastic thyroid cancer cells via the EGFR pathway.
Tong AH; Tan J; Zhang JH; Xu FJ; Li FY; Cao CY
J Biochem Mol Toxicol; 2019 Feb; 33(2):e22241. PubMed ID: 30431689
[TBL] [Abstract][Full Text] [Related]
35. Long noncoding RNA NEAT1 regulate papillary thyroid cancer progression by modulating miR-129-5p/KLK7 expression.
Zhang H; Cai Y; Zheng L; Zhang Z; Lin X; Jiang N
J Cell Physiol; 2018 Oct; 233(10):6638-6648. PubMed ID: 29319165
[TBL] [Abstract][Full Text] [Related]
36. Regulation of autophagy by miR-30d impacts sensitivity of anaplastic thyroid carcinoma to cisplatin.
Zhang Y; Yang WQ; Zhu H; Qian YY; Zhou L; Ren YJ; Ren XC; Zhang L; Liu XP; Liu CG; Ming ZJ; Li B; Chen B; Wang JR; Liu YB; Yang JM
Biochem Pharmacol; 2014 Feb; 87(4):562-70. PubMed ID: 24345332
[TBL] [Abstract][Full Text] [Related]
37. Long non-coding RNA ASMTL-AS1 inhibits tumor growth and glycolysis by regulating the miR-93-3p/miR-660/FOXO1 axis in papillary thyroid carcinoma.
Feng Z; Chen R; Huang N; Luo C
Life Sci; 2020 Mar; 244():117298. PubMed ID: 31953163
[TBL] [Abstract][Full Text] [Related]
38. Silencing of long non‑coding RNA NEAT1 inhibits hepatocellular carcinoma progression by downregulating SMO by sponging microRNA‑503.
Sun C; Xiao T; Xiao Y; Li Y
Mol Med Rep; 2021 Mar; 23(3):. PubMed ID: 33398379
[TBL] [Abstract][Full Text] [Related]
39. LncRNA LINC00152 Increases the Aggressiveness of Human Retinoblastoma and Enhances Carboplatin and Adriamycin Resistance by Regulating MiR-613/Yes-Associated Protein 1 (YAP1) Axis.
Wang Y; Xin D; Zhou L
Med Sci Monit; 2020 Jun; 26():e920886. PubMed ID: 32541644
[TBL] [Abstract][Full Text] [Related]
40. Ferritin Light Chain (FTL) competes with long noncoding RNA Linc00467 for miR-133b binding site to regulate chemoresistance and metastasis of colorectal cancer.
Li Z; Liu J; Chen H; Zhang Y; Shi H; Huang L; Tao J; Shen R; Wang T
Carcinogenesis; 2020 Jun; 41(4):467-477. PubMed ID: 31675755
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
